Objective. To explore the use of external approaches to quality improvement in health care organizations, through a descriptive evaluation of the process and impact of external reviews of clinical governance arrangements at health care provider organizations in the National Health Service (NHS) in England.
An evaluative framework for comparing approaches to external review Purpose: what are the aims and objectives of the system for external review, and how explicitly are they defined?
Organization: who undertakes the organization or implementation of the system for external review, and what is the position and nature of the organization that undertakes this task?
Overall approach: when and how are external reviews initiated, and to what extent are they used universally or targeted, linked to incentives or sanctions of any kind, and made voluntary or mandatory for the organizations reviewed?
Methods: what form does the process of review itself take, in terms of the explicitness of measurement, the use of different sorts of data and data sources, the focus or target of measurement, and the homogeneity of method across reviews?
Results: what is done with the results of the external review, to what organizations or stakeholders are these results provided, and how are they used to bring about change or improvement?
confidential while others are entirely open to public scrutiny; schemes (such as 'Investors in People' and the Chartermark) are used [9] ; health services accreditation schemes have some measure systems for quality improvement while others measure the quality of care directly; some make use of formal proliferated over the last 15 years and now exist for many types of health care organization [10] ; the NHS Litigation and explicit standards and measurements while others rely heavily on subjective reviewer judgements; and some result Authority inspects NHS trust arrangements for managing clinical negligence [11] ; and there are many formal statutory in little or no formal action while others are linked to significant financial or non-financial incentives and sanctions. authorities with the remit to review health care organizations such as the Audit Commission, the National Audit Office, Though all involve some kind of review of an organization's performance by an external or outside body, they may have and the Health and Safety Executive.
With such a miscellany of external review activities in the little more than that in common. In recent years there has been a dramatic international growth in the use of accreditation [4] NHS, it is not surprising that there is considerable overlap, duplication of effort and some conflict over the respective and other forms of external review, despite an almost complete absence of research which demonstrates its value or informs roles and responsibilities of agencies involved in external review. From the point of view of the organizations being its implementation [5] .
The diversity of approaches and methods noted above reviewed, this can be confusing and overwhelming. Since the market-oriented NHS reforms of the late 1980s loosened makes understanding and analysing the use of external review complex. It may be helpful to use the evaluative framework traditional bureaucratic controls over public sector health care provider organizations and increased local managerial set out in Table 1 , which is based upon published work [6, 7] . This suggests that external review programmes are described autonomy [12] , the use of external review has been increased to compensate for the loss of direct managerial oversight under five main headings: their purpose, the organization or agency which runs them; how the overall approach to review [13] , and this has further contributed to a sense of 'inspectorial overload' [14] . is structured; what measurement methods are used within the review; and how the results of the review are presented, Despite the widespread use of external review in the NHS in England, it has not been widely evaluated or researched, disseminated and used.
This paper provides a brief overview of the use of external and its impact on the organizations that are reviewed is not well understood [15] . For example, we know little about the review in the National Health Service (NHS) in England, and then describes one particular example of its implementation, a beneficial or adverse impacts that external review actually has on the performance of reviewed organizations, how much programme of clinical governance review visits to NHS trusts in one region of England, using the framework in Table 1 . external reviews cost (both for the review agency and the reviewed organizations), and which review methods, apIt then presents the results of a qualitative study which explored this process of external review and its impact on proaches or measurement techniques are most valid, reliable and effective in particular contexts. However, there is a large the organizations which took part, and it concludes by outlining the policy implications of those findings and the and growing literature on the use of external review and regulation in settings outside health care [16] [17] [18] . need for further research in this area.
The use of external review in the NHS in England External reviews of clinical governance in the NHS External review is widely used in the NHS in England as a mechanism for quality improvement. For example, the med-In 1997, the current UK government introduced a range of reforms intended to improve the quality of health care in the ical Royal Colleges inspect arrangements for medical training in health care provider organizations [8] ; the ISO9000 quality NHS [19] . At the centre of these new policies was a requirement for health care provider organizations to have management standard and other external quality award 
Results
At the end of the visit day, the clinical governance review team provided some verbal feedback on what they had observed, and their preliminary findings. About 4 weeks later, a written report containing conclusions and recommendations from the team was sent to the trust, which was expected to respond by setting out an action plan within about 3 months of the visit. The report, action plan and further follow-up were then handed over to Regional Office staff responsible for ongoing performance management.
arrangements for clinical governance in place, which was project, describing and evaluating the development of clinical governance in the NHS in the West Midlands [22], we defined as, established a qualitative research study to explore both the a framework through which NHS organizations are ac-process of external review and its impact on NHS trusts. countable for continuously improving the quality of their services and safeguarding high standards of care by creating an environment in which excellence in clinical care will Methods flourish [20] .
Legislation has placed a new statutory duty to provide quality All 47 NHS trusts in the West Midlands agreed to take part health care on providers, and made their boards explicitly in the research. We undertook interviews at each NHS trust accountable for the quality of care [21] .
before they had their clinical governance review team visit In addition, the reforms created a new organization called and again afterwards. We interviewed the chief executive, the Commission for Health Improvement (CHI) which is medical director and/or director of nursing, clinical govtasked with undertaking external reviews of clinical gov-ernance lead (which in many cases was one of the former ernance in health care organizations. Some have seen CHI individuals), and a non-executive director. We also interviewed as a new national health care inspectorate [15] . In the West members of the clinical governance review team when they Midlands region of the NHS, a pilot programme of external had completed most of their visits. In total, 47 NHS trusts reviews of clinical governance was established by the NHS were visited and 151 individuals were interviewed; 12 memExecutive in 1999. The pilot programme is described in Table bers of the clinical governance visiting team were also in-2, using the framework which was outlined in Table 1 . It can terviewed. Each interview was undertaken by a team of two be seen that it followed a relatively conventional format for researchers drawn from four members of the research team external review; a standards-based assessment framework was (K.W., L.L., T.F., L.W.), except in instances where the scheddeveloped, and then survey or review visits were made to all uling of visits meant that only one researcher could be present. 47 NHS trusts in the region, at which their performance was All interviews used an interview schedule (summarized in Table 3 ), and most lasted approximately 45-60 minutes. assessed against the framework. As part of a larger research Each interview was tape recorded, after first seeking the idea. There was often a sense of inspection overload, and some cynicism about the value of such inspections. However, interviewee's consent. Interviews were generally undertaken by two researchers, one of whom led the questioning and some interviewees had a much more positive perspective on external reviews or inspection, seeing the visiting team as a discussion, while the other made a written record of the responses of the interviewee, using the interview schedule as 'critical friend' able to raise concerns without being punitive or unpleasant. a framework. Notes taken by both the interviewing researcher and the note-taking researcher were then transcribed.
All the transcribed interview records were then imported Preparing for the clinical governance review visit into the Ethnograph [23], a computer software package for NHS trusts were required to assemble a portfolio of evidence managing and analysing qualitative research data and a content in advance of the visit itself, and these were often very analysis of the interview records was undertaken. One resizeable documents consisting of several hundred pages of searcher (K.W.) read the interview records and progressively evidence. Most of these materials had been collated rather developed a thematic framework which was used to code than written specifically for the clinical governance review, and group the issues and themes raised by interviewees. All but some NHS trusts had written additional documentation members of the research team read a sample of interview for the portfolio. Interviewees were concerned about the records and then discussed the coding process. The results time required and the workload involved in producing the presented below outline the themes and issues which emerged portfolio of evidence, though some felt the process had some from the interviews, and example quotations from inbenefits for the NHS trust because it forced them to take stock terviewees are used for illustrative purposes.
of their current position. In most NHS trusts responsibility for assembling the portfolio of evidence had been delegated to a middle or junior management level, suggesting it was seen
as an administrative task, rather than a creative or strategic challenge which needed more senior input.
Attitudes and expectations of reviewed
Despite all this preparation, it seemed the portfolio was organizations often not much used during or after the visit itself. Members of the clinical governance review team reported that they The responses of NHS trusts in the West Midlands to the generally spent about 2-3 hours before each visit, often on prospect of the NHS Executive's clinical governance review the night before the visit itself, reading the portfolio of team and its visit varied widely, but most expressed rather evidence. They felt that as they gained in experience, they mixed feelings and expectations. To some extent, their atbecame more skilled in reading and interpreting the portfolio titudes depended on whether they felt ready for such a visit, and particularly in spotting issues which needed to be followed and what its outcome might be. Many drew comparisons up or areas where information was missing. The review visit with other external reviews, inspections or visits that they itself was a very busy day with little or no time spent on the had experienced. Where these past experiences were positive, portfolio of evidence. those interviewed were more likely to view the coming Interviewees thought the portfolio was good at describing clinical governance team visit positively. Where they had been formal structures and arrangements, and setting out pronegative, interviewees were more likely to be sceptical about the value of the forthcoming visit, or even hostile to the cedures or systems for doing things, but not so good at impressed with it. There was an openness here. It gave us a good openness with the work and allowed us to get into dialogue.'
Presentations -'of mixed value. Often acted as a settling Contact with frontline staff -'Afternoon session was mechanism and a vehicle for focusing on certain areas -"hairy" for us as it was not planned.' served as process function rather than the actual content.'
Honesty and openness -'The trusts that got the best out Impact of individuals -'Visit to one area did not go well of it opened up to their whole organization' because of attitude of nurse in that area.'
Contact with frontline staff -'In the afternoon when we Public process -'Felt that external people were looking at visited people their responses were interesting. Usually our dirty washing!' found a lot of impressive people . . Workload -'It was ambitious to do so much in a single day -very exhausting.' demonstrating that those things actually worked, or giving from within the NHS trust and sometimes some from outside as well, rather uncomfortable. any insight into how well they worked. Members of the clinical governance review team expressed rather mixed views
Interviewees suggested a number of ways in which the review process could have been modified to make it work of how well the impression given by the portfolio of evidence was supported by their impression of the NHS trust gained better in future. For example, more opportunity to get information from external stakeholders, more preparation from the review visit itself, but most felt that it largely correlated. time on both sides, more clinician input into the presentations and dialogue during visits, and the use of more review team members with specialist knowledge of the area being reviewed Views of the review visit itself were all cited as potential improvements. We asked members of the clinical governance review team Overall, most NHS trusts believed strongly that the clinical and interviewees within the NHS trusts to reflect on the visit governance review had given a true picture of clinical govprocess itself and to identify learning points from it for them, ernance in their organization. The members of the clinical their organization, or the process itself, and their responses governance review team also generally felt that the visits gave are set out in Table 4 . The clinical governance review team them a true picture of clinical governance in the organizations members valued the opportunities for dialogue, contact with they reviewed, though they sometimes distinguished between frontline clinical staff, honesty on the part of those they met, the image presented by the NHS trust and its senior manand the presence of senior managers and clinicians. They agement, and the impression gained from visits to dewere less impressed with the presentations made during the partments and interaction with clinical staff. Where they felt day, especially if they reduced the scope for other activities. a true picture was not obtained, they generally believed in In contrast, NHS trusts valued the presentations and saw their own ability to identify this situation even if the duration them as their opportunity to showcase their work in a of the visit did not allow them to investigate or resolve it. managed environment. They also valued dialogue and the contact with frontline staff, but were concerned about the Verbal and written feedback from the review impact of individual clinician's behaviour which might be out visits of tune with what they saw as broader clinical opinion. Some found the public nature of the review process, with issues When we asked NHS trust interviewees to reflect on the verbal and written feedback which they received after the being aired or investigated in front of a variety of people Table 5 Views from NHS trusts on verbal and written feedback from external review. et al. (iii) Standardized -'Feedback seemed a foregone conclusion -they had an established model by the time they got to us so they probably said a standard line to us. I felt it was not 'trust-specific' to us.'
(iv) Non-specific -'It did not make much difference to me -it was brief, it had been a very long day, and it was mostly polite phrases. The value was mostly in the written report. It was not very specific.' Table 5 . Although not everyone liked the feedback and the views of the impact of the visit is set out in Table 6 . way it was delivered, very few disagreed with the content in It can be seen that NHS trust interviewees mainly identified any substantive way. Almost no-one indicated that the feed-the raised awareness and involvement of clinical governance, back raised issues of which they were not already aware; they the increased local attention to and momentum of clinical spoke of the feedback confirming things they already knew governance, and the development of an action plan as positive and bringing issues into the open.
impacts. They also suggested that the workload associated Clinical governance review team members largely con-with the visit and its opportunity costs had some negative curred, although there were some differences in emphasis impact. Clinical governance review team members identified and perspective. One difference was that review team mem-similar positive impacts, but did not describe any negative bers did not perceive the feedback to have been demoralizing impacts. There was generally a sense that the visits produced or negative, but generally felt it was balanced and non-confirmation and consolidation rather than challenge, and judgemental. Like interviewees from NHS trusts, clinical few if any major changes in directions were reported. governance review team members felt that there had been little disagreement about the content of feedback, and whatever differences had existed were generally minor matters or issues Discussion which could be easily resolved. Some team members pointed out that NHS trusts got some informal feedback during the In our interviews with both clinical governance review team visit itself, through the dialogue with team members, and so members and NHS trust staff, it became increasingly clear the general tenor of the closing verbal feedback was unlikely that many decisions about how to structure and implement to be surprising, at least to those closely involved in the the external review had been made implicitly, without much review visit. Team members recognized that they had often deliberate consideration of their consequences. Our study not brought any new knowledge to the NHS trusts they suggests that greater attention to the design and development visited, but they emphasized (rather more than those from of external review interventions would be worthwhile, and a NHS trusts we spoke to) the way that they had been able to more rigorous and evaluative approach to design might result 'unlock' knowledge within the organizations they reviewed, in a more robust and effective external review process. opening up issues or making matters explicit which otherwise would have remained unsaid or unspoken.
The aim of the external reviews of clinical governance was Impact on other organizations -'Impact on outsiders' Created internal momentum or leverage -'It has also such as CHC etc -able to see how they could influence given us some leverage to get change -use the review the trust. ' team and the visit as the big bad wolf to get people to accept some changes.'
Impact of process as a whole -'The processCreated workload and diverted effort -'Amount of time requirement for a portfolio and visit -has had a lasting it took and opportunity costs for us. We didn't learn much legacy. ' that we didn't know already and it actually delayed the implementation of some parts of our clinical governance strategy. overtly developmental, and clinical governance review team review, can have a major impact on the overall costs of external review. members reported that this had been reflected in the reality of the visits themselves. However, NHS trusts still viewed It is very difficult to determine the validity and reliability of an assessment provided by external review processes. On and responded to the reviews as inspections, and their reports of the visits themselves stand in contrast to those of review the whole, participants in our study reported that the clinical governance reviews gave a fairly representative and realistic team members. It seems that even when an external review is undertaken with the best of intentions, the process itself picture of clinical governance in their organizations, but it was clear that most also regarded the review process as can be inherently inspectorial, summative and judgemental, at least from the perspective of the organization being relatively subjective and open to bias. The results of the reviews were rarely surprising to any of the participants and reviewed.
The scale and importance of inspection overload is difficult their findings were not generally challenged by NHS trusts, which may be seen as evidence of their face validity. to assess, but our study confirms that reviewed organizations see it as an important problem. At the least, it leads to a The acid test for any system of external review must be its impact on the organizations being reviewed, and especially degree of confusion, fatigue and cynicism about the process within the reviewed organization, and it may detract from whether it leads to real and lasting improvement. Our study confirms that measuring such impacts reliably is difficult, and rather than adding to the quality of health care. If inspection overload is to be prevented or minimized, review agencies that different stakeholders in the external review process may have quite different subjective perceptions of impact. It need to do more to collaborate and coordinate their activities.
It is clear that external reviews can be costly, and that suggests that the clinical governance reviews had some impact on the behaviour of NHS trusts in the West Midlands, at while the costs to the review agency may be considerable, they are probably much less than the costs to the organization least in the short term, and did help to raise awareness of clinical governance and to promote its development in NHS being reviewed. The latter costs may be hidden because they are borne by the organization itself and are not formally trusts. However, it did not seem that the reviews had created substantial changes in policy, strategy or direction in NHS accounted for, but they are nevertheless substantial. Decisions about the design of the review process, such as what written trusts. Moreover, the study suggests that the external reviews had some adverse effects, and may have diverted attention evidence or preparatory material to require in advance of a
